297 results on '"Choo, Eun Ho"'
Search Results
2. Abstract 4139844: Clinical Relevance of FFR-guided PCI According to Left Ventricular Systolic Function in Patients with Acute Myocardial Infarction and Multivessel Disease
Catalog
Books, media, physical & digital resources
3. Optimal timing of percutaneous coronary intervention for non-ST elevated myocardial infarction with congestive heart failure
4. Drug-Coated Balloon Angioplasty in Patients Undergoing Complex Percutaneous Coronary Intervention
5. Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial
6. Clinical Value of Single-Projection Angiography–Derived FFR in Noninfarct-Related Artery
7. Balloon-Expandable Versus Self-Expandable Valve in Transcatheter Aortic Valve Replacement: A Nation-Wide Study
8. Real-world evidence of switching P2Y12 receptor–inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry
9. QFR Assessment and Prognosis After Nonculprit PCI in Patients With Acute Myocardial Infarction
10. Visit-to-visit blood pressure variability and mortality and cardiovascular outcomes after acute myocardial infarction
11. Impact of the risk of malnutrition on bleeding, mortality, and ischemic events in patients with acute myocardial infarction
12. Staged versus immediate complete revascularization for non-culprit arteries in acute myocardial infarction: a post-hoc analysis of FRAME-AMI.
13. Clinical Impact of Dyspnea after Ticagrelor Treatment and the Effect of Switching to Clopidogrel in Patients with Myocardial Infarction.
14. Impact of Intravascular Ultrasound on Long-Term Clinical Outcomes in Patients With Acute Myocardial Infarction
15. Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial
16. Prognosis and the Effect of De-Escalation of Antiplatelet Therapy After Nuisance Bleeding in Patients With Myocardial Infarction
17. Influence of lesion and disease subsets on the diagnostic performance of the quantitative flow ratio in real-world patients
18. J-curve relationship between long term glycemic control and mortality in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention
19. Comparison of successful percutaneous coronary intervention versus optimal medical therapy in patients with coronary chronic total occlusion
20. Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point 18F-FDG PET/CT imaging study
21. Intravascular Imaging-Guided Versus Angiography-Guided PCI: Systematic Review and Meta-analysis of 24 Randomized Controlled Trials
22. The effect of fibrates on lowering low-density lipoprotein cholesterol and cardiovascular risk reduction: a systemic review and meta-analysis
23. TCT-11 Clinical Impact of Dyspnea After Ticagrelor Treatment and the Effect of Switching to Clopidogrel in Patients With Myocardial Infarction
24. TCT-659 De-Escalation of Antiplatelet Therapy in Elderly or Low-Weight Patients With Myocardial Infarction
25. TCT-12 Angiographic Severity of the Nonculprit Lesion and the Efficacy of Fractional Flow Reserve-Guided Complete Revascularization in AMI Patients: FRAMI-AMI Substudy
26. TCT-63 Cost-Effectiveness of Fractional Flow Reserve in Patients With Acute Myocardial Infarction and Multivessel Disease: Prespecified Analysis of FRAME-AMI Trial
27. TCT-31 Intravascular Imaging-Guided Versus Angiography-Guided PCI: Meta-Analysis of 20 Randomized Controlled Trials
28. Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-βl and Smad2/3 pathways in high-fat diet-induced obesity rat model
29. Dual Antiplatelet Therapy De-Escalation in Stabilized Myocardial Infarction With High Ischemic Risk: Post Hoc Analysis of the TALOS-AMI Randomized Clinical Trial.
30. The effect of fibrates on lowering low-density lipoprotein cholesterol and cardiovascular risk reduction: a systemic review and meta-analysis.
31. HEART RATE AT OFFICE VISIT AND LONG-TERM CARDIOVASCULAR EVENTS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
32. Office-Visit Heart Rate and Long-Term Cardiovascular Events in Patients with Acute Myocardial Infarction
33. Role of Statins after Endovascular Repair of Abdominal Aortic Aneurysms: A Nationwide Population-Based Study
34. Impact of Percutaneous Coronary Intervention for Chronic Total Occlusion in Non–Infarct-Related Arteries in Patients With Acute Myocardial Infarction (from the COREA-AMI Registry)
35. Predictors for early cardiac death after discharge from successfully treated acute myocardial infarction
36. Dual antiplatelet therapy de-escalation in acute coronary syndrome: an individual patient meta-analysis
37. Intracoronary Imaging-Guided Revascularization for Non-Culprit Lesions in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease
38. Cost-Effectiveness of Fractional Flow Reserve in Patients with Acute Myocardial Infarction and Multivessel Disease: Prespecified Analysis of FRAME-AM Trial
39. Triple Antiplatelet Therapy with Cilostazol and Favorable Early Clinical Outcomes after Acute Myocardial Infarction Compared to Dual Antiplatelet Therapy with Standard or Potent P2Y12 Inhibitors
40. Clinical benefit of long-term use of dual antiplatelet therapy for acute myocardial infarction patients with the PEGASUS-TIMI 54 criteria
41. Association Between Bleeding and New Cancer Detection and the Prognosis in Patients With Myocardial Infarction
42. Reduced Mortality With Antiplatelet Therapy Deescalation After Percutaneous Coronary Intervention in Acute Coronary Syndromes: A Meta-Analysis
43. Status of hypertension and coronary stenosis in asymptomatic type 2 diabetic patients: Analysis from Coronary Computed Tomographic Angiography Registry
44. High Uric Acid Levels in Acute Myocardial Infarction Provide Better Long-Term Prognosis Predictive Power When Combined with Traditional Risk Factors
45. Impact of Low Baseline Low‐Density Lipoprotein Cholesterol on Long‐Term Postdischarge Cardiovascular Outcomes in Patients With Acute Myocardial Infarction
46. TCT-18 Deescalation of Antiplatelet Therapy in Stabilized Acute Myocardial Infarction Patients With High Ischemic Risk: Post Hoc Analysis of the TALOS-AMI Trial
47. Independent Clinical Impacts of Procedural Complexity on Ischemic and Bleeding Events in Patients with Acute Myocardial Infarction: Long-Term Clinical Study
48. Prognostic Impact of the HFA-PEFF Score in Patients with Acute Myocardial Infarction and an Intermediate to High HFA-PEFF Score
49. Abstract 20089: Efficacy and Safety of Extended Dual Antiplatelet Therapy in Stable Post-myocardial Infarction 1-year Survivors
50. Abstract 16391: Dpp4 Inhibitor Attenuates Obesity Induced Myocardial Fibrosis by Inhibiting TGF-β1 and Smad2/3 Pathways in High-Fat Diet-Induced Obesity Rat
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.